What is the total value of India's pharmaceutical export to Bulgaria?

India exported pharmaceuticals worth $14.4M to Bulgaria across 403 verified shipments.

Who are the top Indian pharmaceutical exporters to Bulgaria?

1. BALKANPHARMA-DUPNITSA AD — $13.5M. 2. RX SOLUTION LIMITED — $417.8K. 3. M/S. RX SOLUTION LIMITED. — $205.1K. Total: 20 suppliers.

Which companies in Bulgaria import pharmaceuticals from India?

1. ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED — $13.5M. 2. NATCO PHARMA LIMITED — $205.1K. 3. EUGIA PHARMA SPECIALITIES LIMITED — $195.0K. 47 buyers total.

What pharmaceutical products does India export most to Bulgaria?

1. Valsartan ($7.2M, 50.0%); 2. Amlodipine ($4.8M, 33.4%); 3. Sodium ($579.9K, 4.0%); 4. Lisinopril ($278.2K, 1.9%); 5. Gliclazide ($261.6K, 1.8%)

Why does Bulgaria import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $14.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Bulgaria?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Bulgaria pharmaceutical trade?

$35.7K per consignment across 403 shipments.

How many Indian pharmaceutical companies export to Bulgaria?

20 Indian companies. Largest: BALKANPHARMA-DUPNITSA AD with $13.5M.

How can I find verified Indian pharmaceutical suppliers for Bulgaria?

TransData Nexus covers 20 active exporters with shipment history and trade values at transdatanexus.com.

Bulgaria to India Pharmaceutical Import (2026) — $14.4M, 20 Foreign Suppliers | TransData Nexus

Bulgaria to India Pharmaceutical Import (2026) — $14.4M, 20 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Bulgaria to India

#	Formulation	Value	Share
1	Valsartan	$7.2M	50.0%
2	Amlodipine	$4.8M	33.4%
3	Sodium	$579.9K	4.0%
4	Lisinopril	$278.2K	1.9%
5	Gliclazide	$261.6K	1.8%
6	Semaglutide	$209.2K	1.5%
7	Pomalidomide	$158.5K	1.1%
8	Simvastatin	$145.1K	1.0%
9	Trastuzumab	$137.1K	1.0%
10	Vildagliptin	$103.9K	0.7%
11	Erythromycin	$43.3K	0.3%
12	Pembrolizumab	$40.7K	0.3%
13	Oseltamivir	$39.0K	0.3%
14	Pazopanib	$36.6K	0.3%
15	Cytarabine	$34.8K	0.2%

India imports 20+ pharmaceutical formulations from Bulgaria with a combined trade value of $14.4M. Key products include Valsartan ($7.2M), Amlodipine ($4.8M), Sodium ($580K), Lisinopril ($278K), Gliclazide ($262K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 403 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Bulgaria to India Trade Routes

1Valsartan$7.2M

2Amlodipine$4.8M

3Sodium$580K

4Lisinopril$278K

5Gliclazide$262K

6Semaglutide

Top Bulgaria Suppliers to India

1Balkanpharma-dupnitsa Ad

$13.5M

2Rx Solution Limited

$418K

3M/s. Rx Solution Limited.

$205K

4Newlife Biopharma Limited

$137K

5M/s Rx Solution Limited

$30K

Trade Statistics

Total Value$14.4M

Shipments403

Indian Exporters20

Bulgaria Buyers47

Avg Shipment$36K

Products78

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Bulgaria Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Bulgaria and India has experienced significant growth over the past decade. In 2022, the total import value from Bulgaria to India was approximately $14.4 million USD, with 403 shipments from 20 Bulgarian suppliers to 47 Indian buyers. This reflects a robust and expanding trade relationship in the pharmaceutical sector.

A notable contributor to this growth is BALKANPHARMA-DUPNITSA AD, which accounted for $13.5 million USD of the total import value, representing 50% of the total imports. This indicates a strong reliance on Bulgarian pharmaceutical products, particularly from this supplier, highlighting the importance of this trade corridor in meeting India's pharmaceutical needs.

2Bulgaria's Role in India's Pharma Imports

Bulgaria plays a significant role in India's pharmaceutical imports, with a total import value of $14.4 million USD in 2022. The top 10 imported products from Bulgaria include Valsartan ($7.2 million USD), Amlodipine ($4.8 million USD), and Sodium ($580,000 USD), among others. These products are essential in treating various cardiovascular and metabolic conditions, underscoring Bulgaria's contribution to India's healthcare sector.

The dominance of Valsartan and Amlodipine in the import list suggests a strategic focus on hypertension and related cardiovascular diseases, areas where Bulgaria's pharmaceutical industry has established expertise. This specialization aligns with India's growing demand for effective treatments in these therapeutic areas.

Bulgaria Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

For Bulgarian pharmaceutical companies aiming to export to India, obtaining approval from the Central Drugs Standard Control Organisation (CDSCO) is mandatory. The registration process involves several key steps:

1. Application Submission: Companies must submit an online application through the CDSCO's SUGAM portal, providing detailed information about the product and manufacturing processes.

2. Document Requirements: Essential documents include a Certificate of Pharmaceutical Product (COPP), Good Manufacturing Practice (GMP) certificate, and a free sale certificate from the country of origin.

3. Review and Approval: CDSCO reviews the application and may conduct inspections to verify compliance with Indian standards.

4. Import License Issuance: Upon successful evaluation, CDSCO issues an import license, allowing the product to be marketed in India.

The entire process can take several months, depending on the complexity of the product and the completeness of the application.

2GMP & Manufacturing Standards

India requires that foreign manufacturing sites adhere to Good Manufacturing Practice (GMP) standards as outlined by the World Health Organization (WHO). Bulgarian manufacturers must ensure their facilities comply with these standards to meet CDSCO's requirements. The CDSCO conducts inspections to verify compliance, and a valid GMP certificate is essential for the registration process.

3Import Documentation

To import pharmaceutical products into India, Bulgarian companies must provide several key documents:

Import License (Form 10): Issued by CDSCO, this license authorizes the importation of specific pharmaceutical products.

Registration Certificate: Confirms that the product has been approved for sale in India.

No Objection Certificate (NOC): Indicates that the product does not infringe on any existing patents or trademarks in India.

Test License: Allows for the testing of the product in India to ensure it meets local standards.

Customs Procedures: Compliance with Indian customs regulations is mandatory, including proper labeling and packaging as per CDSCO guidelines.

TransData Nexus Research · Bulgaria regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Bulgaria identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 403 verified shipments from 20 Indian exporters to 47 Bulgaria buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

20 Exporters

47 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Bulgaria to India Pharmaceutical Import

Top Pharmaceutical Formulations — Bulgaria to India

Top Pharmaceutical Products — Bulgaria to India Trade Routes

Top Bulgaria Suppliers to India

Trade Statistics

Other Import Origins

India–Bulgaria Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Bulgaria's Role in India's Pharma Imports

Top Indian Buyers from Bulgaria

Product Routes

Full Dataset Access

3Recent Developments

Bulgaria Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Bulgaria

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Bulgaria

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Bulgaria Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Bulgaria for Indian Pharma

1India's Import Dependency

2Bulgaria Companies in India

FAQ — India to Bulgaria Pharmaceutical Trade